Superior Planning, LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Superior Planning, LLC’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.2K	Buy	+423	New	+$10.4K	0.01%	859

Other funds holding ADPT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Superior Planning, LLC's ADPT Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 423 shares worth $12.2K. The stake represents 0.01% of the portfolio and ranks #859 among its holdings.

190 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

Superior Planning, LLC held 423 shares of Adaptive Biotechnologies worth $12.2K as of Q3 2026.
Adaptive Biotechnologies was a new Superior Planning, LLC position in Q3 2026.
Adaptive Biotechnologies made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #859 holding.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.